iSpecimen Inc. (ISPC) Financial Statements
Industry: Commercial Physical & Biological Research (Services)
In fiscal 2025, iSpecimen reported revenue of $1.9M, down 79.2% from $9.3M the year before. Net income was -$10.5M (a -543.7% net margin), or -$91.20 per diluted share. Gross margin was 11.2% and operating margin was -465.4%. Operating activities generated -$4.2M of cash, leaving -$4.2M of free cash flow. At fiscal year end, iSpecimen held $9.5M in total assets against $6.4M in total liabilities, including $6.9M of cash and equivalents.
Open the full interactive iSpecimen financials → Quarterly statements, key ratios, valuation history and price charts.
iSpecimen Key Stats
| Share Price | $1.08 |
|---|---|
| Market Cap | $1.5M |
| Revenue YoY Growth | -79.2% |
| 52-Week Range | $1.05 – $34.40 |
| Shares Outstanding | 1.4 million (basic, 2026 Q2) |
iSpecimen Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $11.1M | $10.4M | $9.9M | $9.3M | $1.9M |
| Cost of Goods Sold | $5.2M | $4.8M | $4.8M | $5.3M | $1.9M |
| Gross Profit | $5.9M | $5.6M | $5.1M | $4.2M | $215,665 |
| Operating Income | -$5.9M | -$10.2M | -$11.2M | -$12.7M | -$9.0M |
| Pre-Tax Income | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| Income Tax | $0 | $0 | — | — | — |
| Net Income | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| Diluted EPS | -$1672.00 | -$928.00 | -$984.00 | -$703.20 | -$91.20 |
iSpecimen Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $106,592 | $51,761 | $156,009 | $151,940 |
| Net Income | -$2.8M | -$5.0M | -$2.3M | -$1.4M |
| Diluted EPS | -$19.20 | -$1.09 | -$6.66 | -$0.98 |
iSpecimen Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $27.7M | $15.3M | $2.3M | $1.9M | $6.9M |
| Current Assets | $32.9M | $19.7M | $8.2M | $3.6M | $7.0M |
| Total Assets | $35.7M | $24.6M | $15.8M | $9.4M | $9.5M |
| Current Liabilities | $2.5M | $4.3M | $6.0M | $5.8M | $6.2M |
| Total Long-Term Debt | $3.4M | — | — | — | — |
| Total Liabilities | $5.9M | $4.3M | $6.1M | $6.0M | $6.4M |
| Shareholders' Equity | $29.8M | $20.3M | $9.7M | $3.3M | $3.1M |
iSpecimen Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$10.7M | -$5.8M | -$5.8M | -$8.3M | -$4.2M |
| Cash From Investing | -$1.0M | -$3.2M | -$7.2M | $2.0M | -$1.0M |
| Cash From Financing | $38.7M | -$3.4M | $70,889 | $5.8M | $10.2M |
| Free Cash Flow | -$10.7M | -$6.0M | -$5.8M | -$8.3M | -$4.2M |
Figures from iSpecimen's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full iSpecimen financials page for every line item.
iSpecimen Company Profile
| Ticker | ISPC |
|---|---|
| Exchange | Nasdaq |
| Industry | Commercial Physical & Biological Research (Services) |
| Headquarters | Woburn, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001558569 |
Frequently Asked Questions
What was iSpecimen's revenue in fiscal 2025?
iSpecimen (ISPC) reported revenue of $1.9M for fiscal 2025.
What is iSpecimen's annual revenue history?
iSpecimen's annual revenue by fiscal year: 2021: $11.1M; 2022: $10.4M; 2023: $9.9M; 2024: $9.3M; 2025: $1.9M.
What was iSpecimen's net income in fiscal 2025?
iSpecimen reported net income of -$10.5M for fiscal 2025.
What was iSpecimen's earnings per share (EPS) in fiscal 2025?
iSpecimen's diluted EPS was -$91.20 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did iSpecimen generate in fiscal 2025?
iSpecimen generated -$4.2M of free cash flow in fiscal 2025.
What was iSpecimen's revenue last quarter?
In its most recent reported quarter (2026 Q2), iSpecimen reported revenue of $151,940.
How many shares of iSpecimen are outstanding?
iSpecimen reported a weighted average of 1.4 million basic shares outstanding in 2026 Q2.
What is iSpecimen's market cap?
Based on its latest closing price, iSpecimen (ISPC) has a market capitalization of about $1.5M.
When does iSpecimen's fiscal year end?
iSpecimen's fiscal year end, as registered with the SEC, is December 31.
Where is iSpecimen headquartered?
iSpecimen lists its business address in Woburn, Massachusetts in its SEC filings.
iSpecimen Competitors & Similar Companies
See all 12 Commercial Physical & Biological Research (Services) companies →